AGS/AAO Position Statement on Nicotinamide Use for Glaucoma Neuroprotection episode artwork

EPISODE · Jun 5, 2025 · 18 MIN

AGS/AAO Position Statement on Nicotinamide Use for Glaucoma Neuroprotection

from Ophthalmology Journal

Dr. Emily Schehlein discusses recent guidelines from the American Glaucoma Society and the American Academy of Ophthalmology on Nicotinamide use for glaucoma neuroprotection with lead author, Dr. Aakriti Garg Shukla. Published in Ophthalmology Glaucoma, "American Glaucoma Society-American Academy of Ophthalmology Position Statement on Nicotinamide Use for Glaucoma Neuroprotection" American Glaucoma Society-American Academy of Ophthalmology Position Statement on Nicotinamide Use for Glaucoma Neuroprotection. Shukla, Aakriti Garg; Cioffi, George A.; John, Simon W.M; Wang, Qing; Liebmann, Jeffrey M. et al. Ophthalmology Glaucoma, Volume 8, Issue 2, 112 – 116. Sign up for the next Ophthalmology Journal Virtual Club on August 27, 2025, at https://store.aao.org/ophthalmology-virtual-journal-club.html

Episode metadata supplied by the publisher feed · Published Jun 5, 2025

Embed this episode

Ready to play

AGS/AAO Position Statement on Nicotinamide Use for Glaucoma Neuroprotection

0:00 18:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Ophthalmology Journal?

This episode is 18 minutes long.

When was this Ophthalmology Journal episode published?

This episode was published on June 5, 2025.

Can I download this Ophthalmology Journal episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!